Natco Pharma slips 8% on weak Q4 results; stock hits new low

The company's consolidated net profit more-than-halved at Rs 120 crore in March quarter against Rs 300 crore in the year-ago quarter.

from Latest News http://bit.ly/2JKgPym
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share